Tag Archives: Data

Salesforce Data Recovery Service to Retire in July: Odaseva Provides Businesses with a Plan to Protect Their Data in the Cloud

Salesforce’s plan to end its Data Protection Solution on July 31 adds more challenges for organizations to maintain business continuity. SAN FRANCISCO, CA, MAY 28, 2020 – Odaseva, the unified Data Protection, Data Privacy and DataOps platform, wants to remind Salesforce customers that there is no better time to develop an effective data protection plan,… Read More »

VA apps pose privacy risk to veterans’ healthcare data

The increasing use of apps provided by the Department of Veterans Affairs is meant to improve access to patient health and benefits information in convenient digital platforms. However, members of Congress are worried that this electronic data is vulnerable. “When a veteran downloads an app from the VA’s app store, how much personal information does… Read More »

How to read between the lines of the healthcare data blocking debate

About a year ago, the Department of Health and Human Services first proposed rules to promote sharing and the interoperability of health data to enable patients to electronically access their health information. Many of the top industry players submitted commentary to The Office of the National Coordinator for Health Information Technology and the Centers for… Read More »

Why patients and providers need a model patient data use agreement

Opportunities are growing for individuals to access and aggregate their health data using health apps and patient portals. Most of these services require individuals to enter into agreements with terms that typically do not favor the individual or give the individual agency over their data. A model patient data use agreement with terms that empower… Read More »

Takeda eyes Alunbrig earlier lung cancer use as 2-year data trounce Pfizer’s Xalkori

Pfizer’s aging Xalkori is the drug to beat in ALK-positive non-small cell lung cancer arena. And that’s just the arena Takeda is aiming for with earlier use of its own treatment Alunbrig. After 25 months of treatment, Alunbrig cut the risk of disease progression by 51% compared with Xalkori in ALK inhibitor-naïve NSCLC, as assessed by… Read More »